Bulletin On Aging and Health
Bulletin On Aging and Health
Retirement Wealth in Defined Benefit and Defined Contribution Pension Plans Designing Health Insurance for the Elderly
NBER
person in the 197175 and 19992002 surveys. The authors find that mortality risk fell significantly between the two surveysthe average probability of death within ten years for the adult population (aged 25 to 74) fell from 9.8 percent in the earlier survey to 8.4 percent in the later survey, a drop of 1.4 percentage points or 14 percent. The authors find that the decline in smoking and high blood pressure were the two most important causes of this drop, accounting for 0.9 points and 0.6 points of the drop, respectively. The increase in obesity caused a 0.3 point increase in mortality risk, but this effect was swamped by the positive changes. When the authors convert their results into life expectancies, they find that on net the changes in health behavior over the past thirty years have added 1.8 years to life expectancy at age 25 and 1.4 years to life expectancy at age 65. Finally, the authors use their estimates to predict what mortality rates might be in
the early 2020s if current trends in heath behaviors continue. They note that this is not necessarily a best guess of what the future will hold, since trends in health behaviors may change, but nonetheless provides some insight as to where we may be headed. In their simulations, the share of the population that are current smokers falls from 25 to 15 percent and the share that are overweight and obese rises from 68 percent to 79 percent. Projecting the effect of changes in risk factors on mortality, they find that the drop in smoking would lead to a 0.7 point drop in mortality rates, while
the increase in obesity would lead to a surprisingly large 1.1 point increase in mortality rates. The latter result is due to a jump in the share of the population projected to be obese (as opposed to simply overweight), where health risks are particularly severe. The authors also show that when weight gain is accompanied by good control of blood pressure and cholesterol, it has no effect on mortality. The authors conclude that changes in health behaviors have contributed to a drop in mortality rates over the past thirty years, but caution that future increases in obesity may reverse this trend. Since much
of the impact of obesity occurs through hypertension and high cholesterol, better control of these conditions through medication can help blunt the effects of rising obesity. Evaluating the effect of strategies for improving utilization of and adherence to recommended medications, such as pay-forperformance systems to reward physicians or greater use of information technology, is a high research priority, the authors note.
This research was supported by the U.S. Social Security Administration through grant #10-P98363-2 to the National Bureau of Economic Research.
with all the associated risks. They find that the certainty equivalent for DC plans greatly exceeds that for DB plans for plausible levels of risk aversion. The only case where DB plans have a higher certainty equivalent is for a risk-averse individual in the public sector when future equity returns are lower than past returns. The authors note that there are a num-
ber of simplifications in their analysis. For example, in their analysis workers never withdraw DC balances as a lump sum distribution when changing jobs, though in reality many workers do this, reducing their DC wealth at retirement. Further, their analysis does not allow the length of the workers career or the workers wages to depend on his pension plan arrangements. They note
that further insights on these issues are essential for understanding the long-run effect of the ongoing transition from DB to DC pension plans.
The authors gratefully acknowledge funding from the National Institute on Aging (Grant P01 AG005842).
dissuading sicker patients from consuming office visits and prescription drugs. It is important to note that CalPERS and Medicare are affected quite differently by the increase in cost sharing. Since the majority of CalPERSs expenditures are on office visits and prescription drugs and the majority of Medicares expenditures are on hospital services, the savings from increased cost sharing accrue primarily to CalPERS, while the costs of increased hospitalizations
accrue primarily to Medicare. The studys results have several interesting policy implications. First, they suggest that the doughnut hole in the new Medicare prescription drug benefit could increase Medicares costsas chronically ill patients are faced with paying the full cost of their medications, some will reduce drug use and end up being hospitalized down the road. More generally, the results suggest that in the optimal health insurance plan,
cost sharing would be tied to health status, with chronically ill patients facing lower cost sharing.
Gruber acknowledges financial support from the Kaiser Family Foundation and the National Institute on Aging. Chandra acknowledges financial support from the National Institute on Aging, the National Bureau of Economic Research, and the Nelson Rockefeller Center at Dartmouth College.
ers on the verge of retirement are in poorer health their counterparts 12 years ago. Using a summary health index designed for this study, we find that those born 1948 to 1953 share health risks with the War Baby cohort. This suggests that most of the health decline instead began before the late 1940s. A more complex set of health conclusions emerges from the specific self-reported health measures. Boomers indicate they have relatively more difficulty with a range of everyday physical tasks, but they also report having more pain, more chronic conditions, more drinking and psychiatric problems, than their HRS earlier counterparts. This trend portends poorly for the future health of Boomers as they age and incur increasing costs associated with health care and medications. Using our health index, only those at the 75th percentile or higher are likely to be characterized as having good or better health. WP 12764 Dhaval Dave, Robert Kaestner Health Insurance and Ex Ante Moral Hazard: Evidence from Medicare Basic economic theory suggests that health insurance coverage may cause a reduction in prevention activities, but empirical studies have yet to provide evidence to support this prediction. However, in other insurance contexts that involve adverse health events, evidence of ex ante moral hazard is more consistent. In this paper, we extend the analysis of the effect of health insurance on health behaviors by allowing for the possibility that health insurance has a direct (ex ante moral hazard) and indirect effect on health behaviors. The indirect effect works through changes in health promotion information and the probability of illness that may be a byproduct of insurance-induced greater contact with medical professionals. We identify these two effects and in doing so identify the pure ex ante moral hazard effect. This study exploits the plausibly exogenous variation in health insurance as a result of obtaining Medicare coverage at age 65. We find limited evidence that obtaining health insurance reduces prevention and increases unhealthy behaviors among elderly persons. There is more robust evidence that physician counseling is successful in changing health behaviors. WP 12803 Allan Begosh, John Goldsmith, Ed Hass, Randall W. Lutter, Clark Nardinelli, John A. Vernon Black Box Warnings and Drug Safety: Examining the Determinants and Timing of FDA
Warning Labels Comparing the safety of prescription drugs over time is difficult due to the paucity of reliable quantitative measures of drug safety. Both the academic literature and popular press have focused on drug withdrawals as a proxy for breakdowns in the drug safety system. This metric, however, is problematic because withdrawals are rare events, and they may be influenced by factors beyond a drugs safety profile. In the current paper, we propose a new measure: the incidence and timing of Black Box Warnings (BBWs). BBWs are warnings placed on prescription drug labels when a drug is determined to carry a significant risk of a serious or lifethreatening adverse event. Using a unique data set, one that includes all new molecular entities (NMEs) submitted to the FDA between May 1981 and February 2006, and subsequently approved and marketed, we analyze the timing and incidence of BBWs. Our analyses also use data on several drug characteristics likely to affect the probability a new drug will receive a BBW. We draw several conclusions from our analyses. For example, drugs receiving priority FDA review are more likely to have BBWs at the time of approval than NMEs receiving standard review. We also find that early prescription volume and orphan drug status are associated with an increased likelihood of receiving a BBW. We do not, however, find a significant difference in the rate of BBWs across time cohorts. A comparison of NMEs approved before and after the 1992 Prescription Drug User Fee Act (PDUFA), which authorized the payment of user fees from drug manufacturers to the FDA in an effort to expedite new drug application (NDAs) review times, did not reveal a statistically significant difference in the rate of BBWs. Critics of PDUFA maintain that reduced FDA-approval times under PDUFA have compromised drug safety. We do not find empirical support for this contention. WP 12805 Alan J. Auerbach, Ronald Lee Notional Defined Contribution Pension Systems in a Stochastic Context: Design and Stability Around the world, Pay-As-You-Go (PAYGO) public pension programs face serious long-term fiscal problems due primarily to actual and projected population aging, and most appear unsustainable as currently structured. Some have proposed the replacement of such plans with systems of fully funded private or personal Defined Contribution (DC) accounts, but the difficulties of transition to funded systems have 5
limited their implementation. Recently, a new variety of public pension program known as Notional Defined Contribution or Nonfinancial Defined Contribution (NDC) has been created, with the objectives of addressing the fiscal instability of traditional plans and mimicking the characteristics of funded DC plans while retaining PAYGO finance. Using different versions of the system recently adopted in Sweden, calibrated to US demographic and economic parameters, we evaluate the success of the NDC approach in achieving fiscal stability in a stochastic context. (In a companion paper, we will consider other aspects of the performance of NDC plans in comparison to traditional PAYGO pensions.) We find that the basic NDC scheme is effective at preventing excessive debt accumulation, but does little to prevent significant asset accumulation along many trajectories and on average. With adjustment, however, the NDC approach can be made more stable. WP 12820 M. Kate Bundorf, Melinda Henne, Laurence Baker Mandated Health Insurance Benefits and the Utilization and Outcomes of Infertility Treatments During the last two decades, the treatment of infertility has improved dramatically. These treatments, however, are expensive and rarely covered by insurance, leading many states to adopt regulations mandating that health insurers cover them. In this paper, we explore the effects of benefit mandates on the utilization and outcomes of infertility treatments. We find that use of infertility treatments is significantly greater in states adopting comprehensive versions of these mandates. While greater utilization had little impact on the number of deliveries, mandated coverage was associated with a relatively large increase in the probability of a multiple birth. For relatively low fertility patients who responded to the expanded insurance coverage, treatment was often unsuccessful and did not result in a live birth. For relatively high fertility patients, in contrast, treatment often led to a multiple, rather than a singleton, birth. We also find evidence that the beneficial effects on the intensive treatment margin that have been proposed in other studies are relatively small. We conclude that, while benefit mandates potentially solve a problem of adverse selection in this market, these benefits must be weighed against the costs of the significant moral hazard in utilization they induce.
WP 12837 Rodrigo R. Soares On the Determinants of Mortality Reductions in the Developing World This paper presents and critically discusses a vast array of evidence on the determinants of mortality reductions in developing countries. We argue that increases in life expectancy between 1960 and 2000 were largely independent from improvements in income and nutrition. We then characterize the age and cause of death profile of changes in mortality and ask what can be learned about the determinants of these changes from the international evidence and from country-specific studies. Public health infrastructure, immunization, targeted programs, and the spread of less palpable forms of knowledge all seem to have been important factors. Much of the recent debate has revolved around antagonistic approaches, which are not supported by the evidence discussed here. Finally, the paper suggests that the evolution of health inequality across and within countries is intrinsically related to the process of diffusion of new technologies and to the nature of these new technologies (public or private). WP 12842 Jeffrey R. Brown, Scott J. Weisbenner Who Chooses Defined Contribution Plans? This paper provides new evidence on what types of individuals are most likely to choose a defined contribution (DC) plan over a defined benefit (DB) plan. Making use of administrative data from the State Universities Retirement System (SURS) of Illinois, we study the decisions of nearly 50,000 new employees who
make a one-time, irrevocable choice between a traditional DB plan, a portable DB plan, and an entirely self-managed DC plan. Because the SURS-covered earnings of these employees are not covered under the Social Security system, their choices provide insight into the DB vs. DC preferences of individuals with regard to a primary source of their retirement income. We find that a majority of participants fail to make an active decision and are thus defaulted into the traditional DB plan after 6 months. We also find that those individuals who are most likely to be financially sophisticated are most likely to choose the self-managed DC plan, despite the fact that, given plan parameters, the DC plan is inferior to the portable DB plan under reasonable assumptions about future financial market returns. We discuss both rational and behavioral reasons that might explain this finding. WP 12858 Jonathan Gruber, Kosali Simon Crowd-Out Ten Years Later: Have Recent Public Insurance Expansions Crowded Out Private Health Insurance? The continued interest in public insurance expansions as a means of covering the uninsured highlights the importance of estimates of crowd-out, or the extent to which such expansions reduce private insurance coverage. Ten years ago, Cutler and Gruber (1996) suggested that such crowd-out might be quite large, but much subsequent research has questioned this conclusion. We revisit this issue by using improved data and incorporating the research approaches that have led to varying estimates. We focus in particular on the public insurance expansions of the 19962002 period. Our results
clearly show that crowd-out is significant; the central tendency in our results is a crowd-out rate of about 60%. This finding emerges most strongly when we consider family-level measures of public insurance eligibility. We also find that recent anti-crowd-out provisions in public expansions may have had the opposite effect, lowering take-up by the uninsured faster than they lower crowd-out of private insurance. WP 12870 Dana Goldman, Tomas Philipson Integrated Insurance Design in the Presence of Multiple Medical Technologies The classic theory of moral hazard concerns the insurance of a single good and predicts that co-insurance is larger when the elasticity of demand is higher and when small risks are insured. We extend this analysis to the insurance of multiple goods; for example, the simultaneous insurance of medical services and prescription drugs. We show that when multiple goods are either complements or substitutes--so that a change in co-insurance for one service affects the demand of others--the classic moral hazard results do not hold. For example, the single good model would predict high co-payments for prescription drugs since drug demand is elastic and of modest financial risk. However, a model of multi-good insurance suggests such drug coverage may optimally involve zero or even negative co-insurance when it is a substitute to other services insured such as hospital care or physician services. We summarize some of the empirical evidence in support of markets adopting optimal integrated pricing structures rather than individually optimal pricing structures.
NBER
The National Bureau of Economic Research is a private nonprofit research organization founded in 1920 and devoted to objective quantitative analysis of the American economy. Its officers are: Martin Feldstein President and Chief Executive Officer Susan Colligan Vice President for Administration and Budget Elizabeth E. Bailey Chairman John S. Clarkeson Vice Chairman Contributions to the National Bureau are tax deductible. Inquiries concerning the contributions may be addressed to Martin Feldstein, President, NBER, 1050 Massachusetts Avenue, Cambridge, MA 02138-5398. The NBER Bulletin on Aging and Health summarizes selected Working Papers recently produced as part of the Bureaus program of research. Working Papers are intended to make preliminary research results available to economists in the hope of encouraging discussion and suggestions for revision. The Bulletin is issued for similar informational purposes and to stimulate discussion of Working Papers before their final publication. Neither the Working Papers nor the Bulletin has been reviewed by the Board of Directors of the NBER. The Bulletin is not copyrighted and may be reproduced freely with appropriate attribution of source. Please provide the NBERs Public Information Department with copies of anything reproduced. Individual copies of the NBER Working Papers summarized here (and others) are available free of charge to Corporate Associates. For all others, there is a charge of $5.00 per downloaded paper or $10.00 per hard copy paper. Outside of the United States, add $10.00 per order for postage and handling. Advance payment is required on all orders. To order, call the Publications Department at (617) 868-3900 or visit [Link]/papers. Please have the Working Paper Number(s) ready. Subscriptions to the full NBER Working Paper series include all 700 or more papers published each year. Subscriptions are free to Corporate Associates. For others within the United States, the standard rate for a full subscription is $3200; for academic libraries and faculty members, $2300. Higher rates apply for foreign orders. The on-line standard rate for a full subscription is $1750 and the on-line academic rate is $725. Partial Working Paper subscriptions, delineated by program, are also available. For further information, see our Web site, or please write: National Bureau of Economic Research, 1050 Massachusetts Avenue, Cambridge, MA 021385398. Requests for Bulletin subscriptions, changes of address, and cancellations should be sent to Bulletin, NBER, 1050 Massachusetts Avenue, Cambridge, MA 02138-5398. Please include the current mailing label.